Skip to main content
FunPep Company Limited logo

FunPep Company Limited — Investor Relations & Filings

Ticker · 4881 ISIN · JP3802640007 T Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2026-06-05 Share Issue/Capital Cha…
Country JP Japan
Listing T 4881

About FunPep Company Limited

https://www.funpep.co.jp/en/

FunPep Company Limited is a research and development firm specializing in therapeutic solutions derived from functional peptides. The company leverages the biological properties of peptides—short chains of amino acids—to develop a portfolio of products including pharmaceuticals, medical devices, and functional cosmetics. Its primary focus is on creating peptide-based medicines through two main platforms: functional peptides and antibody-inducing peptides. A key candidate from its functional peptide platform, SR-0379, is in late-stage clinical trials. The company is also advancing an allergy vaccine and developing next-generation formulation technologies for its antibody-inducing peptide platform.

Recent filings

Filing Released Lang Actions
第13回新株予約権（行使価額修正条項付）の大量行使に関するお知らせ
Share Issue/Capital Change Classification · 88% confidence The document is a formal disclosure by Kabushiki Kaisha Fanpeppu with details on the exercise of the 13th series of stock acquisition rights (warrants) and the resulting issuance of new shares. It provides numbers of warrants exercised, share counts, exercise prices, and outstanding warrants—typical of a share issuance/capital change announcement. Therefore, it should be classified under Share Issue/Capital Change (SHA).
2026-06-05 Japanese
第13回新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ
Share Issue/Capital Change Classification · 90% confidence The document is a monthly exercise status announcement for the company’s 13th stock acquisition rights (warrants) with exercise price adjustment clause, detailing the number of options exercised, share issuance amounts, and exercise compliance. This is a notification of new share issuances due to option exercise, fitting the definition of a Share Issue/Capital Change filing (SHA).
2026-06-01 Japanese
Crafton Biotechnologyとの共同研究開始のお知らせ
Regulatory Filings Classification · 89% confidence The document is a corporate announcement of the start of a joint research agreement between the company and Crafton Biotechnology. It contains no financial statements, no management change, no securities issuance, no governance details, nor any request for votes. It is a general regulatory announcement/filing. It falls into the fallback category “Regulatory Filings (RNS).”
2026-06-01 Japanese
第13回新株予約権（行使価額修正条項付）の大量行使に関するお知らせ
Share Issue/Capital Change Classification · 95% confidence The document is a Japanese announcement titled “Notice regarding large-scale exercise of the 13th share subscription rights.” It details the number of share subscription rights exercised, resulting share issuances, and exercise prices. This is a corporate announcement of new share issuance (via exercised warrants) and thus falls under share issue/capital changes, matching code SHA.
2026-05-20 Japanese
第13回新株予約権（行使価額修正条項付）の大量行使に関するお知らせ
Regulatory Filings
2026-04-15 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act to confirm the accuracy of the contents of the Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). The document does not contain the actual financial statements or substantive financial data of the report it references. FY 2025
2026-03-24 Japanese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.